Cyclophosphamide

Descriptions of Cyclophosphamide

Cyclophosphamide: An anticancer drug that belongs to the family of drugs called alkylating agents.
Source: National Institute of Health

Cyclophosphamide: A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. (NCI04)
Source: Diseases Database

Cyclophosphamide : precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent; used in the treatment of lymphomas, leukemias and other cancers, and as an immunosupressive agent to prevent transplant rejection; its side effect, alopecia, has been used for defleecing sheep; may also cause sterility, birth defects, mutations, and cancer.
Source: CRISP

Basic Information: Cyclophosphamide

Count: Cyclophosphamide is listed as a: treatment for 27 conditions; alternative treatment for 0 conditions; preventive treatment for 0 conditions; research treatment for 1 conditions.

Treatments: list of all treatments

List of Diseases with Cyclophosphamide as a Treatment

The following list of conditions have 'Cyclophosphamide' or similar listed as a treatment in our database:

A

• Autoimmune diseases ... cyclophosphamide

C

• Childhood nephrotic syndrome ... cyclophosphamide
• Cryoglobulinemia ... cyclophosphamide

I

• Idiopathic Pulmonary Fibrosis ... Cyclophosphamide (cytoxan)
• Immune Thrombocytopenic Purpura ... cyclophosphamide

L

• Leukemia ... cyclophosphamide
• Lupus ... cyclophosphamide (Cytoxan)

M

• Multifocal motor neuropathy ... cyclophosphamide

P

• Polyarteritis ... cyclophosphamide

S

• Scleritis ... cyclophosphamide
• Systemic Lupus Erythematosus with Hemolytic Anemia, Susceptibility to, 1 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus with Nephritis, Susceptibility to, 1 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus with Vitiligo, Susceptibility to, 1 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 1 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 10 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 11 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 12 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 13 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 2 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 3 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 4 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 5 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 6 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 7 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 8 ... Cyclophosphamide (Cytoxan)
• Systemic Lupus Erythematosus, Susceptibility to, 9 ... Cyclophosphamide (Cytoxan)

W

• Wegener's granulomatosis ... Cyclophosphamide (Cytoxan)

List of Diseases with Cyclophosphamide as a Research Treatment

The following list of conditions have 'Cyclophosphamide' or similar listed as a research treatment or other research area in our database:

S

• Sarcoidosis ... cyclophosphamide

More Treatment Topics

Search Specialists by State and City